APA (7th ed.) Citation

Alape-Girón, A., Moreira-Soto, A., Arguedas, M., Brenes, H., Buján, W., Corrales-Aguilar, E., . . . Gutiérrez, J. M. (2021). Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19. Frontiers in medicine, 8, 743325. https://doi.org/10.3389/fmed.2021.743325

Chicago Style (17th ed.) Citation

Alape-Girón, Alberto, et al. "Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19." Frontiers in Medicine 8 (2021): 743325. https://doi.org/10.3389/fmed.2021.743325.

MLA (9th ed.) Citation

Alape-Girón, Alberto, et al. "Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19." Frontiers in Medicine, vol. 8, 2021, p. 743325, https://doi.org/10.3389/fmed.2021.743325.